-- 摩根士丹利周二发布的研究报告指出，尽管Equifax (EFX)第一季度业绩超出预期，但由于地缘政治不确定性加剧、利率上调以及抵押贷款业务量疲软，该公司维持其2026财年业绩指引不变。 尽管第一季度业绩稳健，但抵押贷款、汽车贷款和信用卡业务量均有所下滑。 然而，该券商表示，预计未来几年消费者信贷状况将有所改善，监管环境将更加有利，利率将有所下调，抵押贷款业务也将出现增长。 该公司长期盈利增长潜力尚未反映在股价中。 报告指出，尽管短期抵押贷款前景仍不明朗，但信用评级机构应会进入多年上升周期，到2028年每股收益将比2025年翻一番。 该券商重申了对该股的“增持”评级，并将目标股价从每股244美元上调至243美元。
Price: $188.40, Change: $-4.02, Percent Change: -2.09%
Clinuvel Pharmaceuticals (ASX:CUV) is unlikely to seek regulatory approval for Scenesse in vitiligo until the Phase 3 CUV105 and CUV107 clinical trials are completed, according to a Friday Jefferies note.The company said on Friday that the European Medicines Agency (EMA) has proposed evaluating the company's Scenesse drug for the treatment of systemic vitiligo based on a "totality of evidence" regulatory approach.Jefferies said that the EMA's decision is a positive for the company because of the high unmet medical need for Vitiligo treatment.The investment firm has pushed back its revenue expectations from Scenesse in vitiligo, which is now expected to begin in the second half of fiscal 2029 rather than fiscal 2028.Jefferies kept a buy rating on Clinuvel and cut its price target to AU$39.20 from AU$40.50.
Australian shares are set to open flat on Monday, as oil prices climbed almost 2% following stalled US-Iran peace negotiations and restricted flows through the Strait of Hormuz, tightening global supply and pushing Brent crude above $107 a barrel.On April 25, the S&P 500 and the Nasdaq Composite rose 0.8% and 1.6%, respectively, while the Dow Jones Industrial Average fell 0.2%.In the macroeconomy, investors are eyeing the release of Australia's consumer price index report on Wednesday.In corporate news, Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.IperionX's (ASX:IPX) titanium powder production operations in Virginia, US, transitioned to an around-the-clock production schedule during the March quarter, advancing from commissioning to continuous operations, according to a Monday filing with the Australian bourse.Australia's benchmark index fell 0.1% or 6.9 points to close at 8,786.50 on April 24.
Cobre (ASX:CBE) has appointed Kaveen Bachoo as chief financial officer, effective April 28, according to a Monday filing with the Australian bourse.Bachoo has over 20 years of finance leadership experience in the mining sector, including executive positions at Glencore.